Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  News  >  Business Leaders  >  Business Leaders Biography

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors 
HomeAll newsMost read newsBusiness Leaders Biography
Portrait de Ulf Mark Schneider
Age : 52
Public asset : 197,068 USD
Country of residence : Unknown
Linked companies : Nestle SA

Summary 
Dr. Ulf Mark Schneider is a Chief Executive Officer & Director at Nestlé SA, a Chairman-Supervisory Board at EUFETS AG, a Chairman-Supervisory Board at Fresenius Medical Care Groupe France SAS and a Chairman-Supervisory Board at Fresenius Medical Care Management AG.

He is on the Board of Directors at Société des Produits Nestlé SA, Nestlé SA, DuPont Safety Resources, FPS Beteiligungs AG, NPBI International BV, FHC Holdings Ltd., Fresenius Kabi USA, Inc., The Consumer Goods Forum, Fresenius Hemocare Netherlands B.V. and Fresenius Kabi España SA. Dr. Schneider was previously employed as an Independent Director by E.I. du Pont de Nemours & Co., a Chief Financial Officer by Fresenius Medical Care AG & Co. KGaA, a Chairman-Management Board by Fresenius SE & Co. KGaA, a Chairman-Supervisory Board by Fresenius Kabi AG, a Member-Supervisory Board by Fresenius Kabi Austria GmbH, a Chairman-Management Board by Fresenius Management SE, a Group Finance Director by Gehe UK Plc, and a Chairman-Supervisory Board by HELIOS Kliniken GmbH.

He also served on the board at APP Pharmaceuticals, Inc. and Fresenius Kabi Pharmaceuticals Holding, Inc. (United States).

He received his MBA from Harvard Business School and a doctorate degree from the University of St. Gallen.


Current positions of Ulf Mark Schneider 
NameTitle Since
Nestle SA
(Food Processing)
Chief Executive Officer & Director 2016
EUFETS AG Chairman-Supervisory Board -
Cereal Partners Worldwide SA Co-Chairman -
Fresenius Medical Care Groupe France SAS Chairman-Supervisory Board -
Fresenius Medical Care Management AG Chairman-Supervisory Board -
NPBI International BV Member-Supervisory Board 2004
DuPont Safety Resources Director 2014
Fresenius Hemocare Netherlands B.V. Member-Supervisory Board -
Fresenius Kabi España SA Member-Supervisory Board -
FHC Holdings Ltd. Director -
The Consumer Goods Forum Director -
Société des Produits Nestlé SA Director 2017
FPS Beteiligungs AG Member-Supervisory Board 2012
Fresenius Kabi USA, Inc. Director -


Ulf Mark Schneider : Personal Network 
NameLinked companies
Laurent Freixe Nestle SA
Cereal Partners Worldwide SA
The Consumer Goods Forum
Société des Produits Nestlé SA
Stephan Sturm Fresenius Hemocare Netherlands B.V.
FPS Beteiligungs AG
Fresenius Kabi España SA
Fresenius Medical Care Management AG
FHC Holdings Ltd.
Paul Bulcke Nestle SA
Cereal Partners Worldwide SA
The Consumer Goods Forum
Wan Ling Martello Nestle SA
Cereal Partners Worldwide SA
Chris Johnson Nestle SA
Cereal Partners Worldwide SA
Patrice Bula Nestle SA
Cereal Partners Worldwide SA
Rainer Baule Fresenius Hemocare Netherlands B.V.
Fresenius Kabi España SA
NPBI International BV
FHC Holdings Ltd.
Peter Brabeck-Letmathe Nestle SA
Ursula Burns Nestle SA
Henri de Castries Nestle SA


Biography of Ulf Mark Schneider 
Ulf Mark Schneider (born 1965) is the current CEO of Fresenius, a $26 billion global health care group.

Life and career
Schneider was born and raised in Germany and became a U.S. citizen in 2003. He holds a doctorate in economics from the University of St. Gallen, Switzerland, and an MBA from Harvard Business School. Schneider joined Fresenius in November 2001 and served as Chief Financial Officer of Fresenius Medical Care before assuming his current position in May, 2003. Previously, he was Group Finance Director for Gehe UK plc., a pharmaceutical wholesale and retail distributor, in Coventry, England. Schneider held several senior executive positions starting in 1989 with Gehe’s majority shareholder, Franz Haniel & Cie. GmbH, a diversified German industrial company. Under Schneider's leadership, Fresenius' revenue has almost tripled, the number of employees has more than tripled and net income has increased approximately eightfold. Since Schneider became CEO, Fresenius has also carried out a number of major strategic acquisitions: the private hospital chain HELIOS Kliniken in 2005; U.S. dialysis provider Renal Care Group, in 2006; U.S. pharmaceutical company APP Pharmaceuticals, in 2008; Liberty Dialysis, another major dialysis provider in the United States, in 2011; and, in 2014, the purchase of 41 hospitals from Rhön-Klinikum, through which HELIOS became the largest private hospital operator in Germany.

The management challenges of global growth and future strategies in the health care and pharmaceutical industries are of particular interest to Schneider.

Schneider chairs the European Advisory Board of Harvard Business School, and serves on the Board of Directors of the American chemical company DuPont.



Source @ Wikipedia



Most Read News 
07/17ELON MUSK : Tesla shares fall after CEO Musk abuses British caver
RE
07/20DANIEL LOEB : Japan firms tap banks for advice as activists circle
RE
07/18JAMES GORMAN : Morgan Stanley boss Gorman hits out at Fed stress tests
RE
07/19MASAYOSHI SON : SoftBank's Son says Japan is 'stupid' to disallow ride-sharing
RE
08:55pSERGIO MARCHIONNE : Fiat Chrysler names Jeep boss to replace stricken CEO Marchionne
RE
07/19JOHN BROWN : General Electric's power unit faces threat in Saudi Arabia
RE
07/16WARREN BUFFETT : Warren Buffett donates $3.4 billion to Gates' and family charities
RE
07/16ULRICH LEHNER : Thyssenkrupp in leadership turmoil as chairman quits
RE
07/15ANTTI HERLIN : Thyssen and Kone owners held merger talks on elevator ops
RE
07/18WARREN BUFFETT : Buffett's Berkshire Hathaway loosens policy on stock buybacks
RE
More news


© 2018 People and Ownership :   
Advertisement
Ulf Mark Schneider : Connections 
Lactalis Nestlé Produits Frais SAS
Metechon AG
FPS Beteiligungs AG
AXA Assurances IARD Mutuelle
Fresenius Hemocare Netherlands B.V.
Ditabis Digital Biomedical Imaging Systems AG
Fresenius Kabi España SA


Latest news about Ulf Mark Schneider 
2017Nestlé Exploring Sale of Its U.S. Confectionery Business -- 2nd Update
DJ
2017Fresenius picks up M&A pace with Akorn, Merck KGaA deals
RE
2017Unilever Joins Race to Shed Food Businesses -- WSJ
DJ
2017Unilever to Restructure, Raise Returns in Wake of Kraft Bid -- 6th Update
DJ
2017Nestle Needs Three-Year 'Time Out' From Organic Growth Target -- CEO
DJ
2017Nestlé Misses Growth Target for Fourth Straight Year -- Update
DJ
2017Nestlé Reports Drop in Sales, Profit -- Update
DJ
More news


Popular Business Leaders 
Paul Achleitner William Ackman Frank Appel Luc Besson Jeff Bezos Lloyd Blankfein Vincent Bolloré Warren Buffett Patrice Caine Vittorio Colao Tim Cook Serge Dassault Michael Dell Oleg Deripaska Patrick Drahi John Edwards Bill Gates Carlos Ghosn James Gorman David Henry Heinrich Hiesinger Carl Icahn Brian Krzanich Daniel Loeb Jack Ma Sergio Marchionne Laurent Mignon Dennis Muilenburg Rupert Murdoch Elon Musk Xavier Niel Frédéric Oudéa Gavin Patterson Georges Plassat Wolfgang Porsche Sumner Redstone Wilbur Ross Howard Schultz Masayoshi Son George Soros Martin Sorrell Rupert Stadler Tidjane Thiam Peter Thiel Viktor Vekselberg John Williamson Martin Winterkorn Steve Wynn Dieter Zetsche Mark Zuckerberg
A-Z Business Leaders